Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced record-setting attendance and virtual
Arlene Padron Jill Fiedler Kelly Shawn Oconnor Rajanikanth Madabushi Simulations Plus Resource Center Drug Administration
Source: sharewise.com